Total planned funding: $639,591,905
Clear active filters
Chemonics International
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Tanzania | $115,602,195 |
| Zambia | $113,507,186 |
| Nigeria | $100,050,183 |
| Mozambique | $57,200,196 |
| Uganda | $49,757,913 |
| Rwanda | $34,000,362 |
| Zimbabwe | $31,502,137 |
| Haiti | $25,875,535 |
| Côte d'Ivoire | $20,569,436 |
| Ethiopia | $16,086,433 |
| Democratic Republic of the Congo | $15,562,193 |
| Vietnam | $13,472,833 |
| Ukraine | $11,670,699 |
| Eswatini | $6,166,486 |
| Kenya | $4,368,423 |
| South Sudan | $4,145,007 |
| South Africa | $3,957,311 |
| Malawi | $2,910,000 |
| Burundi | $2,353,388 |
| Cameroon | $1,877,113 |
| Ghana | $1,750,000 |
| Angola | $1,267,189 |
| Caribbean Region | $1,233,936 |
| Lesotho | $1,000,000 |
| Indonesia | $900,001 |
| Namibia | $800,000 |
| Central America Region | $565,750 |
| Burma | $550,000 |
| Botswana | $500,000 |
| Central Asia Region | $250,000 |
| Cambodia | $140,000 |
Organizational Types
| Private Contractor | $639,591,905 |
Program Areas
| Treatment | $494,118,161 |
| Prevention | $43,912,189 |
| Care | $41,733,596 |
| Governance and Systems | $39,159,116 |
| Testing | $20,668,843 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $360,774,995 |
| HTXS: Treatment: Adult Treatment | $122,170,307 |
| OHSS: Health Systems Strengthening | $31,280,879 |
| HBHC: Care: Adult Care and Support | $26,960,501 |
| HVCT: Testing: HIV Testing and Counseling | $20,668,843 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $17,069,584 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $12,329,904 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $11,390,890 |
| PDTX: Treatment: Pediatric Treatment | $11,172,859 |
| HLAB: Laboratory Infrastructure | $7,430,495 |
| HVTB: Care: TB/HIV | $6,290,675 |
| PDCS: Care: Pediatric Care and Support | $5,682,420 |
| HKID: Care: Orphans and Vulnerable Children | $2,800,000 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,356,000 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,138,157 |
| HMBL: Biomedical Prevention: Blood Safety | $474,023 |
| HVSI: Strategic Information | $447,742 |
| HMIN: Biomedical Prevention: Injection Safety | $153,631 |
Top Partner Programs
Chemonics International:
$639,591,905
View countries